Back to search
FDAFDA · Food and drugs·Recall number D-317-2013

Plavix 75 mg, 30 count bottle, NDC (54868-4070-0), Rx only, Manufactured by Bristol-Meyers Squibb, Bridgewater, NJ 08807, Distributed by Physicians Total Care, Tulsa, OK 74146.

Published May 15, 2013 · Recall initiated: February 8, 2011

Summary

FDA records drug Class III recall D-317-2013, published May 15, 2013 and initiated February 8, 2011. Recalling firm: Physicians Total Care, Inc.; Status: Terminated; Reported quantity: 60 tablets; Lot: Lot # 67JV Exp 08/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).

What to do

Voluntary: Firm initiated · FAX

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Physicians Total Care, Inc.
Distributor
NC
Lot
Lot # 67JV Exp 08/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Plavix 75 mg, 30 count bottle, NDC (54868-4070-0), Rx only, Manufactured by Bristol-Meyers Squibb, Bridgewater, NJ 08807, Distributed by Physicians Total Care, Tulsa, OK 74146. recalled?

Yes. FDA published recall D-317-2013 on May 15, 2013. Reported hazard: Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).

What should I do if I have this product?

Voluntary: Firm initiated · FAX